OverviewSuggest Edit

Vivos Therapeutics is a company that specializes in the treatment of sleep and breathing disorders. It offers Vivos System, a non-surgical, non-invasive, non-pharmaceutical solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA).

TypePublic
Founded2013
HQHighlands Ranch, CO, US
Websitevivoslife.com

Latest Updates

Employees (est.) (Dec 2020)92
Revenue (FY, 2020)$13.1 M(+15%)
Share Price (Jun 2021)$5.8(-2%)
Cybersecurity ratingBMore

Key People/Management at Vivos Therapeutics

R. Kirk Huntsman

R. Kirk Huntsman

Chairman, Chief Executive Officer
Dave Singh

Dave Singh

Founder, Director and Chief Medical Officer
Brad Amman

Brad Amman

Chief Financial Officer
Susie McCullough

Susie McCullough

Sr. Vice President
Raeann Byrnes

Raeann Byrnes

Sr. Vice President
Todd Huntsman

Todd Huntsman

Sr. Vice President
Show more

Vivos Therapeutics Office Locations

Vivos Therapeutics has an office in Highlands Ranch
Highlands Ranch, CO, US (HQ)
9135 S Ridgeline Blvd #100
Show all (1)

Vivos Therapeutics Financials and Metrics

Vivos Therapeutics Revenue

Vivos Therapeutics's revenue was reported to be $13.07 m in FY, 2020
USD

Revenue (FY, 2020)

13.1m

Net income (FY, 2020)

(12.1m)

EBIT (FY, 2020)

(12.0m)

Market capitalization (15-Jun-2021)

102.6m

Closing stock price (15-Jun-2021)

5.8

Cash (31-Dec-2020)

18.2m

EV

86.2m
Vivos Therapeutics's current market capitalization is $102.6 m.
USDFY, 2018FY, 2019FY, 2020

Revenue

3.8m11.4m13.1m

Revenue growth, %

200%

Cost of goods sold

1.1m2.7m

Gross profit

2.7m8.7m
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

1.3m469.4k18.2m

Accounts Receivable

595.2k871.3k1.4m

Prepaid Expenses

673.1k

Current Assets

2.0m2.0m20.4m
Quarterly
USDQ3, 2020

Cash

1.6m

Accounts Receivable

936.7k

Current Assets

3.4m

PP&E

938.2k
Annual
USDFY, 2018FY, 2019FY, 2020

Net Income

(8.4m)(10.8m)(12.1m)

Depreciation and Amortization

610.7k751.2k717.9k

Accounts Payable

246.5k547.6k(274.2k)

Cash From Operating Activities

(5.3m)(5.3m)(5.7m)
Quarterly
USDQ3, 2019Q3, 2020

Net Income

(8.1m)(5.8m)

Depreciation and Amortization

570.5k540.5k

Accounts Payable

259.9k446.8k

Cash From Operating Activities

(3.8m)(2.1m)
USDFY, 2018

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.7 x
Show all financial metrics

Vivos Therapeutics Operating Metrics

Vivos Therapeutics's Patients was reported to be 15 k in Q3, 2020.
Q3, 2020

Dentists Served

1.2 k

Patients

15 k
Show all operating metrics

Vivos Therapeutics Acquisitions / Subsidiaries

Company NameDateDeal Size
BioModeling Solutions, Inc.
First Vivos, Inc.
Vivos Management and Development, LLC
Vivos Therapeutics (Canada) Inc.

Vivos Therapeutics Revenue Breakdown

Embed Graph

Vivos Therapeutics revenue breakdown by business segment: 38.2% from Product Revenue and 61.8% from Service Revenue

Vivos Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Vivos Therapeutics Online and Social Media Presence

Embed Graph

Vivos Therapeutics News and Updates

InvestorBrandNetwork Announces Relentless Dentist Podcast Featuring Vivos Therapeutics Inc. CEO R. Kirk Huntsman

LOS ANGELES, June 09, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces that R. Kirk Huntsman, CEO and Director of Vivos Therapeutics Inc. (NASDAQ: VVOS), recently appeared…

Vivos Therapeutics Founder & Chief Medical Officer Releases New Book Highlighting His Groundbreaking Work

HIGHLANDS RANCH, Colo., May 26, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing,…

Vivos Therapeutics Schedules First Quarter 2021 Financial Results Conference Call

Call Scheduled for Monday, May 17, 2021 at 5:00 pm ET Call Scheduled for Monday, May 17, 2021 at 5:00 pm ET

Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

HIGHLANDS RANCH, Colo., May 11, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sl…

Vivos Therapeutics Announces Pricing of $24 Million Follow-On Offering

HIGHLANDS RANCH, Colo., May 06, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (Nasdaq: VVOS) (“Vivos”), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sl…

Vivos Therapeutics Announces Integrative Cardiologist Dr. Mimi Guarneri as New Medical Director of Clinical Education

HIGHLANDS RANCH, Colo., April 14, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, includin…
Show more

Vivos Therapeutics Frequently Asked Questions

  • When was Vivos Therapeutics founded?

    Vivos Therapeutics was founded in 2013.

  • Who are Vivos Therapeutics key executives?

    Vivos Therapeutics's key executives are R. Kirk Huntsman, Dave Singh and Brad Amman.

  • How many employees does Vivos Therapeutics have?

    Vivos Therapeutics has 92 employees.

  • What is Vivos Therapeutics revenue?

    Latest Vivos Therapeutics annual revenue is $13.1 m.

  • What is Vivos Therapeutics revenue per employee?

    Latest Vivos Therapeutics revenue per employee is $142 k.

  • Who are Vivos Therapeutics competitors?

    Competitors of Vivos Therapeutics include LimFlow, SML and ThermoTek.

  • Where is Vivos Therapeutics headquarters?

    Vivos Therapeutics headquarters is located at 9135 S Ridgeline Blvd #100, Highlands Ranch.

  • Where are Vivos Therapeutics offices?

    Vivos Therapeutics has an office in Highlands Ranch.

  • How many offices does Vivos Therapeutics have?

    Vivos Therapeutics has 1 office.